
FAAH
Fatty Acid Amide Hydrolase (FAAH) is an enzyme that breaks down fatty acid amides, including endocannabinoids like anandamide. These compounds are involved in the regulation of pain, mood, appetite, and memory. Inhibition of FAAH can increase the levels of these signaling molecules, offering potential therapeutic benefits for pain, anxiety, and neurodegenerative diseases. At CymitQuimica, we offer a selection of FAAH inhibitors to support your research in neuroscience, pain management, and endocannabinoid signaling.
Found 63 products of "FAAH"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
FAAH/cPLA2α-IN-1
CAS:<p>FAAH/cPLA2α-IN-1 is a compound that simultaneously inhibits both FAAH and cPLA2α, demonstrating potent activity with half-maximal inhibitory concentrations (</p>Formula:C19H26N4O5Purity:98%Color and Shape:SolidMolecular weight:390.43OMDM-5
CAS:<p>OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).</p>Formula:C26H44N2O3Purity:99.73%Color and Shape:SolidMolecular weight:432.64JP104
CAS:<p>JP104 is an aryl carbamate that irreversibly inhibits fatty acid amide hydrolase (FAAH) with a pIC50 value of approximately 8 [1].</p>Formula:C25H30N2O3Purity:98%Color and Shape:SolidMolecular weight:406.523-Decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone
CAS:<p>3-Decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone (compound 45), having a pI50 of 5.89, shows promise as an inhibitor of fatty acid amide hydrolase (FAAH). Despite its activity, it demonstrates a lack of affinity for cannabinoid receptors CB(1) and CB(2) [1].</p>Formula:C25H32N2OSColor and Shape:SolidMolecular weight:408.6FAAH inhibitor 2
CAS:<p>FAAH Inhibitor 2 (Compound 17b) is an irreversible inhibitor of fatty acid amide hydrolase (FAAH), demonstrating an IC50 value of 0.153 μM [1].</p>Formula:C24H40N2O2Color and Shape:SolidMolecular weight:388.59Sob-AM2
CAS:<p>Sob-AM2 is an effective substrate targeting the fatty acid amide hydrolase (FAAH) expressed in the brain, with a Km of 1.3 μM. It delivers higher concentrations of Sobetirome to the central nervous system at minimal peripheral systemic doses, thereby activating the central thyroid hormone receptor β (TRβ).</p>Formula:C21H27NO3Color and Shape:SolidMolecular weight:341.44MK-3168 (12C)
CAS:<p>MK-3168 (12C) functions as a FAAH inhibitor, exhibiting IC50 values of 1.0 nM, 5.5 nM, and 1.7 nM for human, rhesus, and rat respectively. It demonstrates effective brain uptake and FAAH-specific signaling. Additionally, 11 C MK-3168 is applicable as a FAAH PET tracer.</p>Formula:C21H21ClN4OSColor and Shape:SolidMolecular weight:412.94FAAH/MAGL-IN-1
<p>FAAH/MAGL-IN-1 (SIH 3) inhibits FAAH & MAGL with IC50 of 31 & 29 nM, useful in neuropathic pain research.</p>Formula:C15H9Cl2N3O3Color and Shape:SolidMolecular weight:350.16FAAH/MAGL-IN-2
CAS:<p>FAAH/MAGL-IN-2: potent, reversible, oral FAAH & MAGL inhibitor, IC50: 11/36 nM, may research neuropathic pain, no locomotion issue.</p>Formula:C15H13Cl2N3O3SColor and Shape:SolidMolecular weight:386.25FAAH/MAGL-IN-3
<p>FAAH/MAGL-IN-3 irreversibly inhibits FAAH (IC50: 179 nM) & MAGL (IC50: 759 nM) with low PAMPA permeability.</p>Formula:C21H25N3O6SColor and Shape:SolidMolecular weight:447.5AZ513
CAS:<p>AZ513 is a reversible FAAH inhibitor, exhibiting an IC50 of 551 nM for human FAAH and 27 nM for rat FAAH. It inhibits the hydrolysis of arachidonoyl ethanolamide in HEK293 cells transfected with human FAAH, with an IC50 of 360 nM.</p>Formula:C14H9Cl2N3OColor and Shape:SolidMolecular weight:306.147Dual FAAH/sEH-IN-1
CAS:<p>Dual FAAH/sEH-IN-1 inhibits both sEH (IC50: 9.6 nM) and FAAH (IC50: 7 nM), offering potent anti-inflammatory effects.</p>Formula:C25H22ClN3O3S2Purity:99.89%Color and Shape:SolidMolecular weight:512.04TC-F 2
CAS:<p>TC-F 2 is a FAAH inhibitor.</p>Formula:C26H25N5O2Purity:98%Color and Shape:SolidMolecular weight:439.51

